Recent progress in health effects and biosynthesis of lacto-N-tetraose, the most dominant core structure of human milk oligosaccharide

Human milk oligosaccharides (HMOs), which are a group of complex carbohydrates highly abundant in human milk, have been recognized as critical functional biomolecules for infant health. Lacto-N-tetraose (LNT) is one of the most abundant HMO members and the most dominant core structure of HMO. The promising physiological effects of LNT have been well documented, including prebiotic property, antiadhesive antimicrobial activity, and antiviral effect. Its safety has been evaluated and it has been commercially added to infant formula as a functional ingredient. Because of great commercial importance of LNT, increasing attention has been paid to its highly efficient biological production. In particular, microbial synthesis based on metabolic engineering displays obvious advantages in large-scale production of LNT. This review contains important information about the recent progress in physiological effects, safety evaluation, and biosynthesis of LNT.

[1]  W. Mu,et al.  Biosynthesis of human milk oligosaccharides via metabolic engineering approaches: current advances and challenges. , 2022, Current opinion in biotechnology.

[2]  W. Mu,et al.  Recent progress on health effects and biosynthesis of two key sialylated human milk oligosaccharides, 3'-sialyllactose and 6'-sialyllactose. , 2022, Biotechnology advances.

[3]  J. Gaddy,et al.  Recent advances on human milk oligosaccharide antimicrobial activity. , 2022, Current opinion in chemical biology.

[4]  Xing Zhang,et al.  Enzymatic and chemoenzymatic synthesis of human milk oligosaccharides and derivatives. , 2022, Carbohydrate polymers.

[5]  N. Ab Mutalib,et al.  Exploring the Potential of Human Milk and Formula Milk on Infants’ Gut and Health , 2022, Nutrients.

[6]  W. Mu,et al.  Designing a Highly Efficient Biosynthetic Route for Lacto-N-Neotetraose Production in Escherichia coli. , 2022, Journal of agricultural and food chemistry.

[7]  D. Casero,et al.  Human Milk Oligosaccharides Impact Cellular and Inflammatory Gene Expression and Immune Response , 2022, Frontiers in Immunology.

[8]  Tao Zhang,et al.  Engineering Escherichia coli for the High-Titer Biosynthesis of Lacto-N-tetraose. , 2022, Journal of agricultural and food chemistry.

[9]  W. Mu,et al.  Pathway Optimization and Uridine 5'-Triphosphate Regeneration for Enhancing Lacto-N-Tetraose Biosynthesis in Engineered Escherichia coli. , 2022, Journal of agricultural and food chemistry.

[10]  M. Marzorati,et al.  Human Milk Oligosaccharides and Lactose Differentially Affect Infant Gut Microbiota and Intestinal Barrier In Vitro , 2022, Nutrients.

[11]  Kento Koketsu,et al.  Transporter Engineering Enables the Efficient Production of Lacto-N-triose II and Lacto-N-tetraose in Escherichia coli. , 2022, Journal of agricultural and food chemistry.

[12]  X. Biarnés,et al.  Enzymatic Hydrolysis of Human Milk Oligosaccharides. The Molecular Mechanism of Bifidobacterium Bifidum Lacto-N-biosidase , 2022, ACS catalysis.

[13]  C. Lebrilla,et al.  Host Cell Glycocalyx Remodeling Reveals SARS-CoV-2 Spike Protein Glycomic Binding Sites , 2022, Frontiers in Molecular Biosciences.

[14]  W. Mu,et al.  Human Milk Oligosaccharides: The New Gold Standard for Premium Infant Formula. , 2022, Journal of agricultural and food chemistry.

[15]  F. Lisacek,et al.  In silico analysis of the human milk oligosaccharide glycome reveals key enzymes of their biosynthesis , 2022, Scientific Reports.

[16]  P. de Vos,et al.  Human milk oligosaccharides and non-digestible carbohydrates reduce pathogen adhesion to intestinal epithelial cells by decoy effects or by attenuating bacterial virulence. , 2021, Food research international.

[17]  Feitong Liu,et al.  Human milk oligosaccharides and infant gut microbiota: Molecular structures, utilization strategies and immune function. , 2021, Carbohydrate polymers.

[18]  A. Meyer,et al.  Improvement of the Transglycosylation Efficiency of a Lacto-N-Biosidase from Bifidobacterium bifidum by Protein Engineering , 2021, Applied Sciences.

[19]  M. J. Yebra,et al.  Infant-gut associated Bifidobacterium dentium strains utilize the galactose moiety and release lacto-N-triose from the human milk oligosaccharides lacto-N-tetraose and lacto-N-neotetraose , 2021, Scientific Reports.

[20]  W. Mu,et al.  Metabolic Engineering of Escherichia coli for Efficient Biosynthesis of Lacto-N-tetraose Using a Novel β-1,3-Galactosyltransferase from Pseudogulbenkiania ferrooxidans. , 2021, Journal of agricultural and food chemistry.

[21]  S. Jennewein,et al.  Clinical Evaluation of 16-Week Supplementation with 5HMO-Mix in Healthy-Term Human Infants to Determine Tolerability, Safety, and Effect on Growth , 2021, Nutrients.

[22]  W. Mu,et al.  Metabolic Engineering of Escherichia coli for Lacto-N-triose II Production with High Productivity. , 2021, Journal of agricultural and food chemistry.

[23]  A. Planas,et al.  Transglycosylation Activity of Engineered Bifidobacterium Lacto-N-Biosidase Mutants at Donor Subsites for Lacto-N-Tetraose Synthesis , 2021, International journal of molecular sciences.

[24]  Lianyan L Xu,et al.  Prospecting Human Milk Oligosaccharides as a Defense Against Viral Infections. , 2021, ACS infectious diseases.

[25]  Xiaoying Zhou,et al.  Sialylated human milk oligosaccharides prevent intestinal inflammation by inhibiting toll like receptor 4/NLRP3 inflammasome pathway in necrotizing enterocolitis rats , 2021, Nutrition & Metabolism.

[26]  Daniel Patrick Smith,et al.  Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis , 2020, Gut.

[27]  W. Mu,et al.  Recent advances on 2′-fucosyllactose: physiological properties, applications, and production approaches , 2020, Critical reviews in food science and nutrition.

[28]  Aina Gotoh,et al.  Varied Pathways of Infant Gut-Associated Bifidobacterium to Assimilate Human Milk Oligosaccharides: Prevalence of the Gene Set and Its Correlation with Bifidobacteria-Rich Microbiota Formation , 2019, Nutrients.

[29]  Hai Yu,et al.  A Bacterial β1-3-Galactosyltransferase Enables Multigram-Scale Synthesis of Human Milk Lacto-N-tetraose (LNT) and Its Fucosides. , 2019, ACS catalysis.

[30]  F. Ren,et al.  Human Milk Oligosaccharides Protect against Necrotizing Enterocolitis by Inhibiting Intestinal Damage via Increasing the Proliferation of Crypt Cells. , 2019, Molecular nutrition & food research.

[31]  B. Nidetzky,et al.  Lacto-N-tetraose synthesis by wild-type and glycosynthase variants of the β-N-hexosaminidase from Bifidobacterium bifidum. , 2019, Organic & biomolecular chemistry.

[32]  P. de Vos,et al.  Modulation of Intestinal Epithelial Glycocalyx Development by Human Milk Oligosaccharides and Non‐Digestible Carbohydrates , 2019, Molecular nutrition & food research.

[33]  Steven D. Townsend,et al.  Sialylated variants of lacto-N-tetraose exhibit antimicrobial activity against Group B Streptococcus. , 2019, Organic & biomolecular chemistry.

[34]  G. Kang,et al.  Human milk oligosaccharides, milk microbiome and infant gut microbiome modulate neonatal rotavirus infection , 2018, Nature Communications.

[35]  M. Mikš,et al.  Preclinical safety evaluation of the human‐identical milk oligosaccharide lacto‐N‐tetraose , 2018, Regulatory toxicology and pharmacology : RTP.

[36]  D. Sela,et al.  Inefficient Metabolism of the Human Milk Oligosaccharides Lacto-N-tetraose and Lacto-N-neotetraose Shifts Bifidobacterium longum subsp. infantis Physiology , 2018, Front. Nutr..

[37]  P. Thomson,et al.  Human milk oligosaccharides and infant gut bifidobacteria: Molecular strategies for their utilization. , 2017, Food microbiology.

[38]  R. Dilger,et al.  Dietary Sialyllactose Influences Sialic Acid Concentrations in the Prefrontal Cortex and Magnetic Resonance Imaging Measures in Corpus Callosum of Young Pigs , 2017, Nutrients.

[39]  S. Thurl,et al.  Systematic review of the concentrations of oligosaccharides in human milk , 2017, Nutrition reviews.

[40]  M. Estes,et al.  Milk Oligosaccharides Inhibit Human Rotavirus Infectivity in MA104 Cells. , 2017, The Journal of nutrition.

[41]  D. Aronoff,et al.  Human Milk Oligosaccharides Exhibit Antimicrobial and Antibiofilm Properties against Group B Streptococcus. , 2017, ACS infectious diseases.

[42]  Shujiro Okuda,et al.  Molecular Insight into Evolution of Symbiosis between Breast-Fed Infants and a Member of the Human Gut Microbiome Bifidobacterium longum. , 2017, Cell chemical biology.

[43]  Steven D. Townsend,et al.  Synthesis of lacto-N-tetraose. , 2017, Carbohydrate research.

[44]  D. van Sinderen,et al.  Bifidobacterium breve UCC2003 metabolises the human milk oligosaccharides lacto-N-tetraose and lacto-N-neo-tetraose through overlapping, yet distinct pathways , 2016, Scientific Reports.

[45]  Takuji Yamada,et al.  A key genetic factor for fucosyllactose utilization affects infant gut microbiota development , 2016, Nature Communications.

[46]  Tanya Yatsunenko,et al.  Dietary Isomers of Sialyllactose Increase Ganglioside Sialic Acid Concentrations in the Corpus Callosum and Cerebellum and Modulate the Colonic Microbiota of Formula-Fed Piglets. , 2016, The Journal of nutrition.

[47]  David F. Smith,et al.  Structural basis of glycan specificity in neonate-specific bovine-human reassortant rotavirus , 2015, Nature Communications.

[48]  Brian F. Pfleger,et al.  Efflux systems in bacteria and their metabolic engineering applications , 2015, Applied Microbiology and Biotechnology.

[49]  P. Forsythe,et al.  Attenuation of food allergy symptoms following treatment with human milk oligosaccharides in a mouse model , 2015, Allergy.

[50]  J. Klassen,et al.  Recognition of human milk oligosaccharides by bacterial exotoxins. , 2015, Glycobiology.

[51]  G. Sprenger,et al.  Galactose-limited fed-batch cultivation of Escherichia coli for the production of lacto-N-tetraose. , 2015, Enzyme and microbial technology.

[52]  J. Delgado-García,et al.  Effects of a human milk oligosaccharide, 2'-fucosyllactose, on hippocampal long-term potentiation and learning capabilities in rodents. , 2015, The Journal of nutritional biochemistry.

[53]  G. Sprenger,et al.  Synthesis of the Human Milk Oligosaccharide Lacto‐N‐Tetraose in Metabolically Engineered, Plasmid‐Free E. coli , 2014, Chembiochem : a European journal of chemical biology.

[54]  Hannah D. Holscher,et al.  Human milk oligosaccharides influence maturation of human intestinal Caco-2Bbe and HT-29 cell lines. , 2014, The Journal of nutrition.

[55]  K. Bum-Erdene,et al.  Galectin-3 interactions with glycosphingolipids. , 2014, Journal of molecular biology.

[56]  K. Fukuda,et al.  Recent Advances in Studies on Milk Oligosaccharides of Cows and Other Domestic Farm Animals , 2013, Bioscience, biotechnology, and biochemistry.

[57]  Lars Bode,et al.  Human milk oligosaccharides: every baby needs a sugar mama. , 2012, Glycobiology.

[58]  D. Mills,et al.  Release and utilization of N-acetyl-D-glucosamine from human milk oligosaccharides by Bifidobacterium longum subsp. infantis. , 2012, Anaerobe.

[59]  M. Kitaoka,et al.  Bifidobacterium longum subsp. infantis uses two different β-galactosidases for selectively degrading type-1 and type-2 human milk oligosaccharides. , 2012, Glycobiology.

[60]  Lars Bode,et al.  The human milk oligosaccharide disialyllacto-N-tetraose prevents necrotising enterocolitis in neonatal rats , 2011, Gut.

[61]  G. Armstrong,et al.  Binding of Clostridium difficile toxins to human milk oligosaccharides. , 2011, Glycobiology.

[62]  J. German,et al.  Oligosaccharide Binding Proteins from Bifidobacterium longum subsp. infantis Reveal a Preference for Host Glycans , 2011, PloS one.

[63]  Peng George Wang,et al.  Characterization and synthetic application of a novel beta1,3-galactosyltransferase from Escherichia coli O55:H7. , 2009, Bioorganic & medicinal chemistry.

[64]  K. Fukuda,et al.  Chemical characterization of oligosaccharides in chimpanzee, bonobo, gorilla, orangutan, and siamang milk or colostrum. , 2009, Glycobiology.

[65]  B. Priem,et al.  A new fermentation process allows large-scale production of human milk oligosaccharides by metabolically engineered bacteria. , 2002, Glycobiology.

[66]  G. Sawatzki,et al.  Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. , 2000, The American journal of clinical nutrition.

[67]  T. Lagergård,et al.  Inhibition of Attachment of Streptococcus pneumoniae and Haemophilus influenzae by Human Milk and Receptor Oligosaccharides , 1986 .

[68]  G. Magnusson,et al.  Identification of an active disaccharide unit of a glycoconjugate receptor for pneumococci attaching to human pharyngeal epithelial cells , 1983, The Journal of experimental medicine.